Company Name: |
TargetMol Chemicals Inc.
|
Tel: |
4008200310 |
Email: |
marketing@tsbiochem.com |
Products Intro: |
Product Name:CMLD010509;CMLD-010509,CMLD010509 CAS:256497-58-2 Purity:98% Package:5 mg
|
Company Name: |
RD International Technology Co., Limited
|
Tel: |
18024082417 |
Email: |
market@ubiochem.com |
Products Intro: |
Product Name:CMLD010509 CAS:256497-58-2 Purity:5mg;10mg;50mg;100mg;250mg;500mg;1g Package:5mg;10mg;50mg;100mg;250mg;500mg;1g
|
|
| CMLD010509 Basic information |
Product Name: | CMLD010509 | Synonyms: | CMLD010509;SDS-1-021;CMLD-010509,CMLD010509;1H-Cyclopenta[b]benzofuran-2-carboxamide, 3a-(4-bromophenyl)-2,3,3a,8b-tetrahydro-1,8b-dihydroxy-N,6,8-trimethoxy-3-phenyl-, (1R,2R,3S,3aR,8bS)-rel- | CAS: | 256497-58-2 | MF: | C27H26BrNO7 | MW: | 556.4 | EINECS: | | Product Categories: | | Mol File: | 256497-58-2.mol | ![CMLD010509 Structure](CAS/20210111/GIF/256497-58-2.gif) |
| CMLD010509 Chemical Properties |
density | 1.519±0.06 g/cm3(Predicted) | pka | 11.56±0.70(Predicted) |
| CMLD010509 Usage And Synthesis |
Description | CMLD010509 is a highly specific inhibitor of the oncogenic translation program supporting multiple myeloma (MM)-including key oncoproteins such as MYC, MDM2, CCND1, MAF, and MCL-1. |
| CMLD010509 Preparation Products And Raw materials |
|